Cidara Therapeutics has announced an expanded and accelerated Phase 3 [...]

AstraZeneca has reported positive interim results from the Phase 3 [...]

MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]

Cook MyoSite and Veristat have reached a key enrolment milestone [...]

Pharvaris has adjusted its guidance for topline results from its [...]

FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

Funding to advance EO2463 through Phase 1/2 and prepare for [...]

The National Institute for Health and Care Excellence (NICE) has [...]